Treating mitochondrial diseases with antibiotics
- 18 January 2021
- journal article
- news
- Published by Springer Science and Business Media LLC in Nature Metabolism
- Vol. 3 (1), 5-6
- https://doi.org/10.1038/s42255-020-00336-w
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Tetracyclines promote survival and fitness in mitochondrial disease modelsNature Metabolism, 2021
- Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein SynthesisImmunity, 2021
- NAD plus Regeneration Rescues Lifespan, but Not Ataxia, in a Mouse Model of Brain Mitochondrial Complex I DysfunctionCell Metabolism, 2020
- Strategies for fighting mitochondrial diseasesJournal of Internal Medicine, 2020
- Mitochondrial Diseases: Hope for the FutureCell, 2020
- Targeting NAD+ Metabolism as Interventions for Mitochondrial DiseaseScientific Reports, 2019
- Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammalsThe Journal of cell biology, 2017
- Hypoxia as a therapy for mitochondrial diseaseScience, 2016
- mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh SyndromeScience, 2013
- Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndromeProceedings of the National Academy of Sciences of the United States of America, 2010